Background: Estimates of attributable costs of stroke are scarce, as most prior studies do not account for the baseline health care costs in people at risk of stroke. We estimated the attributable costs of stroke in a universal health care setting and their variation across stroke types and several social determinants of health.
Methods: We undertook a population-based administrative database-derived matched retrospective cohort study in Ontario, Canada. Community-dwelling adults aged ≥40 years with a stroke between 2003 and 2018 were matched (1:1) on demographics and comorbidities with controls without stroke. Using a difference-in-differences approach, we estimated the mean 1-year direct health care costs attributable to stroke from a public health care payer perspective, accounting for censoring with a weighted available sample estimator. We described health sector-specific costs and reported variation across stroke type and social determinants of health.
Results: The mean 1-year attributable costs of stroke were Canadian dollars 33 522 (95% CI, $33 231-$33 813), with higher costs for intracerebral hemorrhage ($40 244; $39 193-$41 294) than ischemic stroke ($32 547; $32 252-$32 843). Most of these costs were incurred in acute care hospitals ($15 693) and rehabilitation facilities ($7215). Compared with all patients with stroke, the mean attributable costs were higher among immigrants ($40 554; $39 316-$41 793), those aged <65 years ($35 175; $34 533-$35 818), and those residing in low-income neighborhoods ($34 687; $34 054-$35 320) and lower among rural residents ($29 047; $28 362-$29 731).
Conclusions: Our findings of high attributable costs of stroke, especially in immigrants, younger patients, and residents of low-income neighborhoods, can be used to evaluate potential health care cost savings associated with different primary stroke prevention strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/STROKEAHA.123.043369 | DOI Listing |
J Hazard Mater
January 2025
Departamento de Química Orgánica y Bio-Orgánica, Universidad Nacional de Educación a Distancia (UNED), Avenida de Esparta s/n, Las Rozas de Madrid 28232, Spain. Electronic address:
Magnetite nanoparticles have been successfully used for removal and immobilization of contaminants in water, yet their application in soils combined with in situ magnetic separation remains unexplored. We evaluated the effectiveness and optimal conditions for using magnetite nanoparticles combined with magnetic separation to remove metal(loid)s from contaminated mine soils. Soil samples were incubated (15, 45 days) with varying doses of magnetite (0, 25, 50 g kg⁻¹) and moisture (dry, field capacity) and separated using electromagnet or permanent magnet.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Amsterdam Neuroscience, Neurodegeneration, Amsterdam, Netherlands.
Background: We hypothesise that improved diagnostic precision, operationalised by adding amyloid positron emission tomography (PET) to the diagnostic work-up in a memory clinic, is beneficial for long-term health and healthcare cost outcomes. We investigated whether a more precise diagnosis influenced institutionalisation and mortality incidence trajectories, and annual healthcare costs over a period up to eight years.
Method: Between October 2014 and December 2016, patients from the Amsterdam Dementia Cohort were offered an amyloid-PET as part of their diagnostic work-up.
Alzheimers Dement
December 2024
University Hospital Llandough, Llandough, United Kingdom.
Background: How and why healthcare utilisation and costs vary between patients with Alzheimer's disease dementia (ADD) is not well understood but is important in ensuring that efforts to improve the diagnosis and treatment of ADD are prioritised effectively. We aimed to investigate variation in healthcare resource utilisation (HCRU) among patients with ADD in England and identify the clinical and demographic factors which characterise subpopulations with the highest HCRU.
Method: This was a retrospective cohort study using Discover, a linked electronic health record database of 2.
Alzheimers Dement
December 2024
Institute for Health Metrics and Evaluation, Seattle, WA, USA.
Background: There are 6.7 million people living with dementia in the United States, and this number is projected to increase as the population ages. The cost of informal care makes up a large proportion of the societal costs of dementia due to the significant care needs associated with the condition.
View Article and Find Full Text PDFIt is well recognised that Alzheimer's disease and related dementia disorders (ADRD) are associated with very high societal costs. The total global costs of dementia have been estimated to over 1.3 trillion US$ annually (Wimo, Seeher et al.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!